NCT02686333View on ClinicalTrials.gov

Meditation for Depression and Anxiety Symptoms in Dialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 1, 2017

Study Completion Date

December 31, 2017

Conditions
DepressionAnxiety
Interventions
OTHER

Meditation

10-15 minutes of individually conducted medication practices (silent meditations, guided meditations, body scans, gentle arm movement exercises).

Trial Locations (1)

H3T 1A2

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

University Health Network, Toronto

OTHER

collaborator

Sunnybrook Health Sciences Centre

OTHER

lead

Lady Davis Institute

OTHER

NCT02686333 - Meditation for Depression and Anxiety Symptoms in Dialysis Patients | Biotech Hunter | Biotech Hunter